e-learning
resources
Virtual 2020
Pre-Congress Content
Screening and early lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prevalence of occult N2/3 NSCLC in tumours with a central location, size larger than 3cm or N1 disease on imaging: a single-centre retrospective study.
F. Liew (London, United Kingdom), K. Groom (London, United Kingdom), A. Shearer (London, United Kingdom), C. Ross (London, United Kingdom), R. Sinharay (London, United Kingdom)
Source:
Virtual Congress 2020 – Screening and early lung cancer
Session:
Screening and early lung cancer
Session type:
E-poster session
Number:
1616
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Liew (London, United Kingdom), K. Groom (London, United Kingdom), A. Shearer (London, United Kingdom), C. Ross (London, United Kingdom), R. Sinharay (London, United Kingdom). The prevalence of occult N2/3 NSCLC in tumours with a central location, size larger than 3cm or N1 disease on imaging: a single-centre retrospective study.. 1616
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
The efficacy and safety of induction chemoradiotherapy (ICRT) followed by surgery in stage III NSCLC patients (pts) with T3/4-adjacent organ invasion involved(AOI): A single-center retrospective observational study.
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Relevance of clinical TNM-staging in small cell lung cancer (SCLC) for survival – A retrospective case study in 633 patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study
Source: ERJ Open Res, 6 (4) 00061-2020; 10.1183/23120541.00061-2020
Year: 2020
An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU)
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018
The causes and consequences for dose reduction in NSCLC IIIB patients, a retrospective single center clinical trial.
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Evaluation of gene mutation status and metastasis in lung adenocarcinoma: a multicentric prospective study in Turkey
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
The diagnostic value of integrated PET/CT in solitary pulmonary nodules in an area with the world‘s highest recorded incidence of tuberculosis (a pilot study)
Source: Annual Congress 2010 - State of the art imaging
Year: 2010
Clinical strategy in patients with multiple synchronous suspect lung lesions. A reflection on the current TNM classification based on 54 cases with complete follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001
EBUS-TBNA for the diagnosis of centrally located primary lung lesions: a retrospective series
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
Videothoracoscopic lung biopsy (VATS-LB) in the diagnosis of diffuse interstitial lung disease (DILD) and evaluation of an outpatient surgical approach. A prospective multicentric study
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study
Source: Eur Respir J, 50 (6) 1701493; 10.1183/13993003.01493-2017
Year: 2017
A retrospective study of the cause and impact of delayed diagnosis of lung cancer (LC)
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
TNM and survival in small cell lung cancer: results of a population-based study
Source: Eur Respir J 2001; 18: Suppl. 33, 394s
Year: 2001
A preliminary comprehensive hormonal evaluation on a prospective group of patients (pts) with advanced lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
The role of radial endobronchial ultrasound for peripheral lung cancer tissue sampling and prognostic biomarkers analysis – a single-center retrospective study
Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration
Year: 2019
A multicenter phase II study of docetaxel (D) weekly in advanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts): preliminary results of the 0202 GFPC study
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005
Preliminary analysis of a multicenter phase III trial comparing docetaxel (D) versus docetaxel/cisplatin (DC) in patients with inoperable advanced and metastatic non small cell lung cancer (NSCLC)
Source: Annual Congress 2003 - Advanced lung cancer treatment
Year: 2003
Unsuspected N2 disease: A retrospective analysis comparing survival in patients with suspected N2 disease in non-small cell lung cancer
Source: International Congress 2017 – Thoracic surgery
Year: 2017
Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine
Source: Eur Respir J 2005; 26: Suppl. 49, 537s
Year: 2005
Long time survival after resection for multiple primary lung cancers. A population-based study
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept